Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2005;112:2581

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Search for Related Content
Related Collections
Right arrowRelated Articles

(Circulation. 2005;112:2581.)
© 2005 American Heart Association, Inc.

Issue Highlights


*    HYBRID APPROACHES TO THORACIC AORTIC ANEURYSMS: THE ROLE OF ENDOVASCULAR ELEPHANT TRUNK COMPLETION, by Greenberg et al.
up arrowTop
*HYBRID APPROACHES TO THORACIC...
down arrowMORTALITY AFTER ACUTE MYOCARDIAL...
down arrowSILDENAFIL INHIBITS ß...
down arrowCardiology Patient Page
down arrowImages in Cardiovascular...
down arrowCorrespondence
 
The era of endovascular stenting of the thoracic aorta is advancing to include novel techniques to extend the versatility of these devices. Thoracic aortic aneurysms affecting the aortic arch and descending thoracic aorta have required a 2-stage operative procedure. The first stage is performed through a sternotomy and includes replacement of the ascending aorta and aortic arch and leaving an extension of the graft in the descending aorta (elephant trunk). The second-stage procedure is performed via a left thoracotomy, retrieving the elephant trunk and extending the graft to replace the appropriate extent of the descending aorta. In the report, "Hybrid Approaches to Thoracic Aortic Aneurysms: The Role of Endovascular Elephant Trunk Completion," by Roy Greenberg, Fady Haddad, Lars Svensson, Sean O’Neill, Daniel Clair, Sean P. Lyden, Esteban Walker, and Bruce Lytle, the authors describe a series of patients where endovascular grafting was employed to complete the second stage of the procedure, ie, extending the elephant trunk. Thus, the second-stage operation was avoided. The procedure was feasible, reducing the morbidity and mortality associated with an open operative approach. See p 2619.


*    MORTALITY AFTER ACUTE MYOCARDIAL INFARCTION IN HOSPITALS THAT DISPROPORTIONATELY TREAT BLACK PATIENTS, by Skinner et al.
up arrowTop
up arrowHYBRID APPROACHES TO THORACIC...
*MORTALITY AFTER ACUTE MYOCARDIAL...
down arrowSILDENAFIL INHIBITS ß...
down arrowCardiology Patient Page
down arrowImages in Cardiovascular...
down arrowCorrespondence
 
Race-related disparities in management of cardiac disorders have been well documented, but data on the impact of such inequalities on health outcomes are limited. In this issue of Circulation, Skinner and colleagues evaluated prospective data from more than a million fee-for-service Medicare patients treated in 4289 US hospitals between 1997 and 2001. The investigators examined if short-term mortality after an acute myocardial infarction (AMI) varied according to race by dividing hospitals into deciles based on the percent of AMI patients who were black. They observed that 90-day post-MI mortality was higher (23.7%) in hospitals serving a larger proportion of blacks (top decile) relative to hospitals without any black AMI patients (lowest decile; mortality rate of 20.1%). The higher post-MI mortality in hospitals with a greater fraction of black patients was not explained by differences in patient characteristics (infarct severity, comorbidity) or hospital income, ownership status, volume, region, urban status, or surgical treatment intensity. The authors speculate that differences in quality of care in hospitals catering to blacks versus whites may have contributed to these disparities in outcome. These observations raise the possibility that improving quality of care in hospitals that disproportionately serve blacks may help reduce the race-related gaps in outcomes of AMI patients. See p 2634.


*    SILDENAFIL INHIBITS ß-ADRENERGIC–STIMULATED CARDIAC CONTRACTILITY IN HUMANS, by Borlaug et al.
up arrowTop
up arrowHYBRID APPROACHES TO THORACIC...
up arrowMORTALITY AFTER ACUTE MYOCARDIAL...
*SILDENAFIL INHIBITS ß...
down arrowCardiology Patient Page
down arrowImages in Cardiovascular...
down arrowCorrespondence
 
Sildenafil and the related agents in this class of widely used drugs inhibit the 5A isoform of phosphodiesterase, an enzyme that degrades cGMP, resulting in increased levels of this intercellular signaling molecule. Although it is well known that cGMP is a potent vasodilator, the role of cGMP in regulating myocardial function has not been as clear. This study found that a single administration of sildenafil blunted the systolic contractile response to ß-adrenergic receptor stimulation in patients. These findings suggest that cGMP opposes ß-adrenergic signaling in the human myocardium and can cause a measurable decrement in systolic function. The clinical implications of this finding remain to be determined. See p 2642.

Visit http://www.circ.ahajournals.org:


*    Cardiology Patient Page
up arrowTop
up arrowHYBRID APPROACHES TO THORACIC...
up arrowMORTALITY AFTER ACUTE MYOCARDIAL...
up arrowSILDENAFIL INHIBITS ß...
*Cardiology Patient Page
down arrowImages in Cardiovascular...
down arrowCorrespondence
 
Heart Attack and Stroke Prevention in Women. See p e273.


*    Images in Cardiovascular Medicine
up arrowTop
up arrowHYBRID APPROACHES TO THORACIC...
up arrowMORTALITY AFTER ACUTE MYOCARDIAL...
up arrowSILDENAFIL INHIBITS ß...
up arrowCardiology Patient Page
*Images in Cardiovascular...
down arrowCorrespondence
 
Carotid Plaque Reduction After Medical Treatment. See p e276.

Renal Fibromuscular Dysplasia. See p e278.

Functional Subclavian Artery Compression Caused by Thoracic Outlet Syndrome. See p e280.



View larger version (129K):
[in this window]
[in a new window]
 


*    Correspondence
up arrowTop
up arrowHYBRID APPROACHES TO THORACIC...
up arrowMORTALITY AFTER ACUTE MYOCARDIAL...
up arrowSILDENAFIL INHIBITS ß...
up arrowCardiology Patient Page
up arrowImages in Cardiovascular...
*Correspondence
 
See p e282.


Related Articles:

Hybrid Approaches to Thoracic Aortic Aneurysms: The Role of Endovascular Elephant Trunk Completion
Roy K. Greenberg, Fady Haddad, Lars Svensson, Sean O’Neill, Esteban Walker, Sean P. Lyden, Daniel Clair, and Bruce Lytle
Circulation 2005 112: 2619-2626. [Abstract] [Full Text]

Mortality After Acute Myocardial Infarction in Hospitals That Disproportionately Treat Black Patients
Jonathan Skinner, Amitabh Chandra, Douglas Staiger, Julie Lee, and Mark McClellan
Circulation 2005 112: 2634-2641. [Abstract] [Full Text]

Sildenafil Inhibits ß-Adrenergic–Stimulated Cardiac Contractility in Humans
Barry A. Borlaug, Vojtech Melenovsky, Tricia Marhin, Patricia Fitzgerald, and David A. Kass
Circulation 2005 112: 2642-2649. [Abstract] [Full Text]

Heart Attack and Stroke Prevention in Women
Richard C. Becker
Circulation 2005 112: e273-e275. [Full Text]

Carotid Plaque Reduction After Medical Treatment
Gilda Stivali, Franca Cerroni, Palma Bianco, Pamela Fiaschetti, and Rosario Cianci
Circulation 2005 112: e276-e277. [Full Text]

Renal Fibromuscular Dysplasia
D. P. McLaughlin, R. V. Kelly, R. A. Santa-Cruz, and G. A. Stouffer
Circulation 2005 112: e278-e279. [Full Text]

Functional Subclavian Artery Compression Caused by Thoracic Outlet Syndrome
Gianluca Rigatelli, Massimo Rinuncini, Loris Roncon, Massimo Giordan, and Pietro Zonzin
Circulation 2005 112: e280-e281. [Full Text]

Letters Regarding Article by Patti et al, "Randomized Trial of High Loading Dose of Clopidogrel for Reduction of Periprocedural Myocardial Infarction in Patients Undergoing Coronary Intervention: Results From the ARMYDA-2 (Antiplatelet therapy for Reduction of MYocardial Damage during Angioplasty) Study" Response
Pierluigi Tricoci, Robert A. Harrington, Marco Valgimigli, Theresa M. Palabrica, Paul B. Burton, Giuseppe Patti, Leonardo Lassandro Pepe, Germano Di Sciascio, Giuseppe Colonna, Antonio Montinaro, and Vincenzo Pasceri
Circulation 2005 112: e282-e283. [Full Text]




This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Search for Related Content
Related Collections
Right arrowRelated Articles